iCardio:基于巴西人口的心血管疾病的真实世界数据平台
Miriam Allein Zago Marcolino1,2, Ana Paula Beck da Silva Etges1,2, Luciana Rodrigues de Lara1,2
1National Institute of Science and Technology for Health Technology Assessment (IATS)-CNPq/Brazil (project: 465518/2014-1), Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.
Mayo Clinic proceedings. Digital health
|September 2, 2025
概括
iCardio平台为巴西的心血管保健提供真实数据分析. 这种开放的工具通过数据驱动的洞察力提高了心血管服务的效率,质量和公平性.
科学领域:
- 心血管医学
- 卫生信息学
- 公共卫生政策
背景情况:
- 技术进步对于提高医疗保健效率和减少浪费至关重要.
- 管理复杂的护理服务需要强大的数据管理系统.
- 巴西的心血管领域面临着数据可访问性和分析方面的挑战.
研究的目的:
- 介绍iCardio的实施, 这是一个在线开放式分析解决方案,
- 提供一个用户友好的平台来评估心血管服务的效率,质量和公平性.
- 支持巴西心血管领域的数据驱动健康政策和研究.
主要方法:
- 开发了一个基于网络的分析平台 (iCardio),使用人口现实世界的数据.
- 利用巴西卫生部 (2019-2020) 的住院和死亡数据.
- 综合了558个医疗中心291,490名患者的数据,包括心血管手术和干预手术.
主要成果:
- iCardio平台提供了对心血管保健评估的17个关键指标.
- 功能包括4个分析视图:患者简介,基于位置的分析,手术率和详细的探索.
- 数据可以根据患者特征,程序,医疗中心和地理位置进行分层.
结论:
- iCardio是巴西真实心血管数据的有价值的开放资源.
- 该平台可以作为支持数据驱动健康政策的转型工具.
- 促进研究和明智的决策, 以改善全国的心血管保健.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
332
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
332
Cardiovascular Drugs: Classification based on Therapeutic Indications
3.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.2K
Coronary Artery Disease IV: Preventive Measures
32
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
32
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Cardiomyopathy I: Introduction and Classification
50
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
50
Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45


